Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
API
0
FDF
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 6-(acetylamino)hexanoic Acid
2. 6-acetamidohexanoic Acid
3. 6-acetylaminocaproic Acid
4. 6-acetylaminocaproic Acid, Calcium Salt
5. 6-acetylaminocaproic Acid, Monosodium Salt
6. Acexamic Acid
7. Celuton
8. Cy168e
9. Epsilon-acetylaminocaproic Acid
10. N-acetylamino-6-hexanoic Acid
11. Nas-501
12. Plastenan
13. Sodium Acexamate
14. Zinc Acexamate
1. Zinc Acexamate
2. 70020-71-2
3. Zinc;6-acetamidohexanoate
4. 811d513q1n
5. Hexanoic Acid, 6-(acetylamino)-, Zinc Salt (2:1)
6. Copinal
7. Unii-811d513q1n
8. Copinal (tn)
9. Acexamate Zinc
10. Zinc 6-(acetylamino)hexanoate (2:1)
11. Schembl1643738
12. Acexamate Zinc [who-dd]
13. Dtxsid20220304
14. Zinc Acexamate [ep Monograph]
15. Zinc N-(acetylamino)-6-hexanoate
16. Db-082106
17. Ft-0687297
18. D07558
19. .epsilon.-acetamidocaproic Acid Zinc Salt
20. .epsilon.-acetamidocaproic Acid Zinc Salt [mi]
21. Q27269190
Molecular Weight | 409.8 g/mol |
---|---|
Molecular Formula | C16H28N2O6Zn |
Hydrogen Bond Donor Count | 2 |
Hydrogen Bond Acceptor Count | 6 |
Rotatable Bond Count | 10 |
Exact Mass | 408.123878 g/mol |
Monoisotopic Mass | 408.123878 g/mol |
Topological Polar Surface Area | 139 Ų |
Heavy Atom Count | 25 |
Formal Charge | 0 |
Complexity | 151 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 3 |
Anti-Inflammatory Agents, Non-Steroidal
Anti-inflammatory agents that are non-steroidal in nature. In addition to anti-inflammatory actions, they have analgesic, antipyretic, and platelet-inhibitory actions. They act by blocking the synthesis of prostaglandins by inhibiting cyclooxygenase, which converts arachidonic acid to cyclic endoperoxides, precursors of prostaglandins. Inhibition of prostaglandin synthesis accounts for their analgesic, antipyretic, and platelet-inhibitory actions; other mechanisms may contribute to their anti-inflammatory effects. (See all compounds classified as Anti-Inflammatory Agents, Non-Steroidal.)
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?